MyHerb (CEO Yang Hyuk) participated in the 3th International Medical Equipment and Hospital Equipment Exhibition ‘KIMES 23’ held at COEX, Seoul from March 26rd (Thursday) to 38th (Sunday).
MyHub is a company that has developed and supplied medical devices and service platforms optimized for medical sites. We have actively utilized our extensive human network based on medical professionals, and at the same time, we have successfully entered into the market in a short period of time by successfully conducting technical cooperation and strategic alliances with medical AI companies and medical institutions.
At this exhibition, MyHub introduced ‘mai-Link’, an AI-based integrated medical service platform, a mobile X-ray system, and ‘BoneBon’, console software to assist in bone age reading.
mai-Link is a platform that provides medical imaging AI solutions for various medical imaging devices (modalities) such as Started providing services. We are supplying medical AI and software from developers such as ‘Lunit’, ‘Vuno’, ‘AIinsight’, and ‘Neurophet’ to domestic hospitals and clinics.
By providing customized services to apply and optimize various developers and software to the modality equipment owned by each hospital and clinic, the company expands the supply of excellent software to the domestic medical community and, as a result, contributes to raising the standard of medical service quality. This is the side explanation.
The portable It provides the function of identifying the presence or absence of five major findings, including ▲nodules ▲sclerosis ▲interstitial shadows ▲pleural effusion ▲pneumothorax, and the location of abnormal areas. Additionally, the screening function can be used to screen for pneumonia and pulmonary tuberculosis using a combination of existing findings.
This product provides confidence in judgment (abnormality score) when abnormal findings are discovered and is specialized for intensive reading of abnormal patient images by analyzing multiple images simultaneously.
BoneBon is console software that assists in determining bone age based on the ‘Greulich-Pyle (GP)’ bone age model learned with AI after acquiring X-ray images. The expected bone age of up to 3 ranks is suggested to the user based on the most similar age range defined in the GP method.
In addition, it provides three types of predicted height (TW3, BP, and V-Score) and genetic predicted height, and a growth report including the predicted height can also be provided to the patient. At the same time, based on the read bone age and actual age, results such as whether the current patient is within the normal range, analysis information, current body mass index (BMI), and obesity level results can also be obtained.
A MyHub official said, “We are proud of being the first company in Korea to launch a medical AI platform, and each developer is also actively supplying products based on the trust they have in us,” adding, “As a platform leader, we are entering medical AI.” “The company’s vision and goal is to lower barriers and increase supply rates so that any patient in any region can enjoy high-quality medical services,” he said.
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
In KIMES 2023, new technologies and products suitable for the era of convergence, such as smart healthcare in the era of the 4th industrial revolution, robot medical care and eco-friendly medical waste facilities, advanced hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation, will be presented. showed off In addition, various information was provided, including seminars on medical technology, new technologies, and overseas marketing, as well as domestic medical industry policy seminars to show the latest information and the direction of the medical industry.